Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2016, Article ID 2421540, 3 pages
http://dx.doi.org/10.1155/2016/2421540
Case Report

A Rare Case of Mediterranean Spotted Fever and Encephalitis

3rd Department of Internal Medicine, Hospital Distrital de Santarém, Santarém, Portugal

Received 28 July 2016; Revised 7 November 2016; Accepted 22 November 2016

Academic Editor: Xavier Vallès

Copyright © 2016 Raquel Sousa Almeida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Colomba, C. Imburgia, M. Trizzino, and L. Titone, “First case of Mediterranean spotted fever-associated rhabdomyolysis leading to fatal acute renal failure and encephalitis,” International Journal of Infectious Diseases, vol. 26, pp. e12–e13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Duque, C. Ventura, D. Seixas et al., “Mediterranean spotted fever and encephalitis: a case report and review of the literature,” Journal of Infection and Chemotherapy, vol. 18, no. 1, pp. 105–108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Demeester, M. Claus, M. Hildebrand, E. Vlieghe, and E. Bottieau, “Diversity of life-threatening complications due to Mediterranean spotted fever in returning travelers,” Journal of Travel Medicine, vol. 17, no. 2, pp. 100–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Amaro, F. Bacellar, and A. França, “Report of eight cases of fatal and severe Mediterranean spotted fever in Portugal,” Annals of the New York Academy of Sciences, vol. 990, pp. 331–343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Brouqui, F. Bacellar, G. Baranton et al., “Guidelines for the diagnosis of tick-borne bacterial diseases in Europe,” Clinical Microbiology and Infection, vol. 10, no. 12, pp. 1108–1132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Jensenius, P.-E. Fournier, and D. Raoult, “Rickettsioses and the international traveler,” Clinical Infectious Diseases, vol. 39, no. 10, pp. 1493–1499, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. D. H. Walker and D. Raoult, “Rickettsia rickettsii and other spotted fever group rickettsiae (Rocky Mountain spotted fever and other spotted fevers),” in Douglas and Bennett's Principles and Practice of Infectious Diseases, Vo. G. L. Mandell, J. E. Bennett, and R. Dolin, Eds., pp. 2035–2042, Churchill Livingstone, New York, NY, USA, 5th edition, 2000. View at Google Scholar
  8. D. I. Montasser, Y. Zajjari, A. Alayoud et al., “Acute renal failure as a complication of Mediterranean spotted fever,” Nephrologie et Therapeutique, vol. 7, no. 4, pp. 245–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Aliaga, P. Sánchez-Blázquez, J. Rodríguez-Granger, A. Sampedro, M. Orozco, and J. Pastor, “Mediterranean spotted fever with encephalitis,” Journal of Medical Microbiology, vol. 58, no. 4, pp. 521–525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Nau, F. Sörgel, and H. Eiffert, “Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections,” Clinical Microbiology Reviews, vol. 23, no. 4, pp. 858–883, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J.-M. Rolain, L. Stuhl, M. Maurin, and D. Raoult, “Evaluation of antibiotic susceptibilities of three rickettsial species including Rickettsia felis by a quantitative PCR DNA assay,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 9, pp. 2747–2751, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Rolain, M. Maurin, G. Vestris, and D. Raoult, “In vitro susceptibilities of 27 rickettsiae to 13 antimicrobials,” Antimicrobial Agents and Chemotherapy, vol. 42, no. 7, pp. 1537–1541, 1998. View at Google Scholar · View at Scopus
  13. A. Cascio, C. Colomba, S. Antinori, D. L. Paterson, and L. Titone, “Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial,” Clinical Infectious Diseases, vol. 34, no. 2, pp. 154–158, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Cascio, C. Colomba, D. Di Rosa, L. Salsa, L. Di Martino, and L. Titone, “Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: a randomized controlled trial,” Clinical Infectious Diseases, vol. 33, no. 3, pp. 409–411, 2001. View at Publisher · View at Google Scholar · View at Scopus